Alpha 2.0
Login Register
» Articles » PMID: 7515263

Frequency of Raised Alpha-fetoprotein Level Among Chinese Patients with Hepatocellular Carcinoma Related to Hepatitis B and C

Overview
Journal Br J Cancer
Specialty Oncology
Date 1994 Jun 1
PMID 7515263
Citations 12
Authors
J F Tsai
W Y Chang
J E Jeng
M S Ho
Z Y Lin
J H Tsai
Affiliations
Soon will be listed here.
Abstract

Antibody to hepatitis C virus (anti-HCV) was found to be an independent risk factor for hepatocellular carcinoma and raised serum alpha-fetoprotein (AFP) level. In addition, the frequency of raised AFP in patients with anti-HCV was higher than in those without (91.5% vs 65.2%, P = 0.0001).

Citing Articles

Second-line treatment of advanced hepatocellular carcinoma: Time for more individualized treatment options?.

Rajappa S, Rau K, Dattatreya P, Ramaswamy A, Fernandes P, Pruthi A World J Hepatol. 2022; 14(6):1074-1086.

PMID: 35978665 PMC: 9258252. DOI: 10.4254/wjh.v14.i6.1074.

A recommendation for the management of lesions of unknown malignancy in multiple primary malignant neoplasm patients: A case report.

Xia X, Cui K Oncol Lett. 2014; 8(6):2744-2746.

PMID: 25364458 PMC: 4214459. DOI: 10.3892/ol.2014.2601.

Serum alpha-fetoprotein level is higher in hepatitis C than hepatitis B infected chronic liver disease patients.

Emokpae M, Adejumol B, Abdu A, Sadiq N Niger Med J. 2014; 54(6):426-9.

PMID: 24665160 PMC: 3948968. DOI: 10.4103/0300-1652.126302.

Performance of serum α-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic mass.

Chan S, Mo F, Johnson P, Siu D, Chan M, Lau W HPB (Oxford). 2013; 16(4):366-72.

PMID: 23980880 PMC: 3967889. DOI: 10.1111/hpb.12146.

Hepatocellular carcinoma in developing countries: Prevention, diagnosis and treatment.

Kew M World J Hepatol. 2012; 4(3):99-104.

PMID: 22489262 PMC: 3321496. DOI: 10.4254/wjh.v4.i3.99.

References
1.
Chen D, SUNG J . Relationship of hepatitis B surface antigen to serum alpha-fetoprotein in nonmalignant diseases of the liver. Cancer. 1979; 44(3):984-92. DOI: 10.1002/1097-0142(197909)44:3<984::aid-cncr2820440328>3.0.co;2-6. View
2.
Lee H, Chung Y, Kim C . Specificities of serum alpha-fetoprotein in HBsAg+ and HBsAg- patients in the diagnosis of hepatocellular carcinoma. Hepatology. 1991; 14(1):68-72. DOI: 10.1002/hep.1840140112. View
3.
Jeng J, Tsai J . Hepatitis C virus antibody in hepatocellular carcinoma in Taiwan. J Med Virol. 1991; 34(1):74-7. DOI: 10.1002/jmv.1890340113. View
4.
Sheu J, Huang G, Shih L, Lee W, Chou H, Wang J . Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma. Gastroenterology. 1992; 103(4):1322-7. DOI: 10.1016/0016-5085(92)91523-7. View
5.
Tsai J, Jeng J, Chang W, Lin Z, Tsai J . Hepatitis C virus infection among patients with chronic liver disease in an area hyperendemic for hepatitis B. Scand J Gastroenterol. 1994; 29(6):550-2. DOI: 10.3109/00365529409092471. View